Taipei Medical University Institutional Repository:Item 987654321/64658
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 45073/58249 (77%)
Visitors : 2396827      Online Users : 172
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://libir.tmu.edu.tw/handle/987654321/64658


    Title: 高良薑抑制體脂肪堆積之研究
    Studies of Alpinia officinarum on Inhibition of Lipid Accumulations in vitro and in vivo
    Authors: 孫佑正
    SUN, YU-CHENG
    Contributors: 生藥學研究所碩士班
    侯文琪
    Keywords: 肥胖;脂肪堆積;DPPH自由基清除能力;非酵素醣基化反應;脂肪細胞;高脂飼料
    Obesity;Lipid accumulation;DPPH radical scavenging;non-enzymatic glycation;adipocytes;high-fat diet
    Date: 2024-07-15
    Issue Date: 2024-11-06 15:54:36 (UTC+8)
    摘要: 肥胖是世界重要的公共衛生問題,人們需將肥胖視為疾病並積極預防與治療。隨著永續環保議題興起,人們開始提倡食物療法,藥食同源是其中重要且具有治療潛力的選擇。近年來,許多文獻證實了薑科植物的抗氧化、抗發炎和改善代謝不良的效果。在這些植物中,高良薑 (Alpinia officinarum Hance) 是一種在中國、東南亞和歐洲被廣泛用於香料的草本植物,在中國長久以來也被用作中藥使用。為了研究傳統中藥高良薑 (Alpiniae officinarum Rhizoma) 的抗肥胖效果,本研究以細胞實驗進行篩選,配合高脂飼料餵食脂動物實驗。結果顯示,高良薑乙醇抽取物有效降低了3T3-L1細胞的脂質生成;進一步將乙醇抽取物分配萃取,獲得之分層區分物中,乙酸乙酯分層區分物 (EA) 在降低3T3-L1細胞的脂質生成方面顯示出最佳效果;進一步研究從EA分離出的8種RV純化合物,其中具有1,7-二苯基庚烷結構的RV107與RV133,和具有類黃酮結構的RV129,在降低3T3-L1細胞的脂質生成方面顯示出最佳效果 (IC50 = 73.43 ± 1.05 μM、89.61 ± 3.06 μM、68.45 ± 4.28 μM)。並經由細胞活性測試、生物能量代謝與即時定量聚合?連鎖反應,進一步研究EA以及純化合物RV107、RV133與RV129,對3T3-L1前脂肪細胞分化的影響,發現最主要作用於分化前期(0~2天),且能降低分化相關基因的表現量,具有抑制分化的能力。動物實驗結果顯示,在進食累積飼料沒有顯著差異下,乙醇抽取物、EA與RV129能顯著減少高脂飼料誘導肥胖小鼠的體重增加,並改善了血糖耐受性。這些結果顯示,高良薑具能有效改善肥胖和脂質累積的能力,並擁有可以開發為保健品與改善肥胖藥物的潛力。
    Obesity is a significant global public health issue. With the rise of sustainable and environmental issues, food and medicine with the same origin of Traditional Chinese Medicine (TCM) has become important and potentially therapeutic choices. In recent years, data from numerous studies have confirmed that many plants in the Zingiberaceae family exhibit effects of antioxidant, anti-inflammatory, and improved metabolic dysfunctions. Among these plants, Alpinia officinarum Hance (Galangal) is a widely used as a spice resource and herbal plant. The extracts, partitioned fractions, and purified compounds of Alpiniae officinarum Rhizoma (AO) were used to investigate anti-obesity effects using differentiated 3T3-L1 adipocytes as cell models and high-fat diet-induced obese animal models. It was found that the ethanol extract of AO effectively reduced lipid accumulations in differentiated 3T3-L1 adipocytes during 8-day cultures. Among partitioned fractions of ethanol extract, the ethyl acetate fraction (EA) showed the best reduction activities in lipid accumulations in 8-day differentiated 3T3-L1 adipocytes. The eight purified compounds from EA fraction were used to identify the active components in reducing lipid accumulations in 8-day differentiated 3T3-L1 adipocytes. Among them, RV107 and RV133, which have a 1,7-diphenylheptane skeleton, and RV129, which has a flavonoid skeleton, exhibited the best activities in reducing lipid accumulations in differentiated 3T3-L1 adipocytes (IC50 = 73.43 ± 1.05 μM, 89.61 ± 3.06 μM, and 68.45 ± 4.28 μM, respectively). By means of different cell viability assays, extracellular flux analysis, and real-time quantitative PCR, the possible mechanisms of EA and the RV compounds (RV107, RV133, and RV129) on inhibition of lipid accumulations in early differentiated 3T3-L1 adipocytes (0-4 day) were investigated. It was found that the gene expressions were reduced during the 0-2 day differentiated phase, which might reduce lipid accumulations in the end. The high-fat diet-induced ICR mice obesity, and at the same time, the co-oral administration showed that ethanol extract, EA, and RV129 significantly reduced weight gains under the same feed intakes, and also improved glucose intolerance. These findings suggest that Alpiniae officinarum Rhizoma has the potential to be developed into anti-obesity therapeutic drugs and health supplements.
    描述: 碩士
    指導教授:侯文琪
    口試委員:侯文琪
    口試委員:王靜瓊
    口試委員:梁有志
    附注: 論文公開日期:2029-07-22
    数据类型: thesis
    显示于类别:[Graduate Institute of Pharmacognosy Science] Dissertation/Thesis

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML0检视/开启


    在TMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈